In our preliminary data, we found that PCSN probes were internalized by targeted HER2-overexpressing breast cancer cells, which implies that better control of the local concentration of silica nanoparticles may facilitate their use as an adjuvant in conjunction with ionizing radiation to target cancer cells while avoiding damage to normal cells. The gene discussed is ERBB2; the disease is cancer.